SymBio Pharmaceuticals Limited

TSE:4582 Stock Report

Market Cap: JP¥10.7b

SymBio Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

SymBio Pharmaceuticals has a total shareholder equity of ¥6.4B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥7.2B and ¥794.0M respectively.

Key information

0%

Debt to equity ratio

JP¥0

Debt

Interest coverage ration/a
CashJP¥6.36b
EquityJP¥6.45b
Total liabilitiesJP¥794.00m
Total assetsJP¥7.24b

Recent financial health updates

Recent updates

We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

Sep 24
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Aug 06
SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Jun 11
Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

Feb 09
Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

Dec 18
If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

Financial Position Analysis

Short Term Liabilities: 4582's short term assets (¥7.2B) exceed its short term liabilities (¥789.0M).

Long Term Liabilities: 4582's short term assets (¥7.2B) exceed its long term liabilities (¥5.0M).


Debt to Equity History and Analysis

Debt Level: 4582 is debt free.

Reducing Debt: 4582 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 4582 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 4582 has sufficient cash runway for 2 years if free cash flow continues to grow at historical rates of 32.6% each year.


Discover healthy companies